Gene: ZNF106
Official Full Name: zinc finger protein 106provided by HGNC
Gene Summary: Enables RNA binding activity. Predicted to be involved in insulin receptor signaling pathway. Predicted to be located in nuclear speck and nucleolus. Predicted to be active in cytosol and membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20288 | ZNF106 Knockout cell line (HeLa) | Human | ZNF106 | 1:3~1:6 | Negative | Online Inquiry |
KO20289 | ZNF106 Knockout cell line (HCT 116) | Human | ZNF106 | 1:2~1:4 | Negative | Online Inquiry |
KO20290 | ZNF106 Knockout cell line (HEK293) | Human | ZNF106 | 1:3~1:6 | Negative | Online Inquiry |
KO20291 | ZNF106 Knockout cell line (A549) | Human | ZNF106 | 1:3~1:4 | Negative | Online Inquiry |
ZNF106 Gene Knockout Cell Lines are genetically engineered cellular models that feature the targeted deletion of the ZNF106 gene, which encodes a zinc finger protein implicated in various cellular processes, including gene regulation and stress response. These cell lines serve as vital tools for elucidating the functional roles of ZNF106 in health and disease, particularly in understanding its contributions to cancer biology, neurodegeneration, and cellular senescence.
The key mechanism of action of ZNF106 Gene Knockout Cell Lines lies in their ability to lack the expression of ZNF106, allowing researchers to observe the phenotypic consequences of its absence. By comparing these knockout models to wild-type cell lines, scientists can assess cellular behaviors such as proliferation, apoptosis, and response to stimuli, thereby improving our understanding of the pathways influenced by this gene. This research is crucial for identifying potential therapeutic targets and elucidating the underlying mechanisms of disease processes related to ZNF106 dysfunction.
The scientific importance of ZNF106 Gene Knockout Cell Lines extends beyond basic research; they have significant implications in drug discovery and development. By providing a clearer understanding of the molecular pathways involved in disease, these cell lines can facilitate the identification of novel drug candidates and therapeutic strategies.
What sets our ZNF106 Gene Knockout Cell Lines apart from alternative models is their high specificity and reliability, utilizing advanced CRISPR/Cas9 gene-editing technology to ensure that the knockout efficiency is maximized while minimizing off-target effects. This precision allows researchers to obtain consistent results, making them particularly valuable for reproducibility in experiments.
For researchers, clinicians, and pharmaceutical developers, ZNF106 Gene Knockout Cell Lines represent a crucial resource that can enhance experimental design and lead to breakthroughs in understanding the biological functions of ZNF106. Our commitment to quality and innovation, backed by years of experience in providing high-fidelity biological products, assures you that each cell line is meticulously characterized and validated for optimal performance in your studies. Partnering with us means gaining access to high-quality tools that can accelerate your research into transformative therapies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.